Skip to content

Thomas Owen Genese, MD MBA FACP

NPI 1922111632ActiveIndividual· Internal Medicine· Binghamton, NY

Internal Medicine (MD MBA FACP) in Binghamton, New York, licensed in NY, with an NPI issued in August 2006. Part D covered 400 prescriptions written in 2024, 81% of them generic. Teva Pharmaceuticals USA, Inc. reported $124.42 in payments in 2025, mostly food and beverage.

Overview

NPI1922111632
StatusActive
Entity typeIndividual
CredentialMD MBA FACP
Sole proprietorNo
NPI issuedAug 16, 2006
Last updated in NPPESMay 28, 2021
Certified by providerMay 28, 2021

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000X248735NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (NY)

Part D prescriptions in 2024

Prescriptions (claims)400 · 929 30-day fills
Patients196
Total drug cost$60,094
Generic share81% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$124.42 · 1 payment from 1 company
  • 2024$124.42 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Teva Pharmaceuticals USA, Inc.$124.421

What the 2025 payments were for

  • Food and Beverage$124.42 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other internal medicine physicians in Binghamton

All 60 internal medicine physicians in Binghamton · All internal medicine physicians in New York